Effects of Propofol on Endotoxin-Induced Acute Lung Injury in Rabbit

Journal of Korean Medical Science

Volumn 19, Issue 1, 2004, Pages 55-61

  Kwak, Sang Hyun ^a   Choi, Jeong Il ^a   Park, Jong Tae ^a  

^a Chonnam National University   (South Korea)

Author keywords

Acute lung injury; Endotoxins; Propofol; Respiratory distress syndrome, adult

Indexed keywords

ALBUMIN; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 8; OXYGEN; PROPOFOL; SODIUM CHLORIDE; THROMBOXANE B2;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRY WEIGHT; HEART RATE; IMMUNE RESPONSE; LEUKOCYTE COUNT; LUNG INJURY; LUNG LAVAGE; LUNG VENTILATION; LUNG WEIGHT; MALE; MEAN ARTERIAL PRESSURE; NEUTROPHIL; NONHUMAN; OXYGENATION; PROTEIN DETERMINATION; RABBIT; RANDOMIZATION; SCORING SYSTEM; SEPSIS; THROMBOCYTE COUNT;

EID: 1542273262     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.1.55     Document Type: Article

References (37)

1. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med 1995; 332: 27-37.
2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
3. Sloane PJ, Gee MH, Gottlieb JE, Albertine KH, Peters SP, Burns JR, Machiedo G, Fish JE. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis 1992; 146: 419-26.
4. Vasilyev S, Schaap RN, Mortensen JD. Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units. An international, multicenter, prospective survey. Chest 1995; 107: 1083-8.
5. Knaus WA, Sun X, Hakim RB, Wagner DP. Evaluation of definitions for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150: 311-7.
6. Repine JE. Scientific perspective on adult respiratory distress syndrome. Lancet 1992; 339: 466-9.
7. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot-Pocidalo MA. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996; 154: 594-601.
8. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154: 602-11.
9. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145: 1016-22.
10. Jacobs RF, Tabor DR, Burks AW, Campbell GD. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140: 1686-92.
11. Okumura Y, Inoue H, Fujiyama Y, Bamba T. Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats. J Gastroenterol 1995; 30: 379-86.
12. McCord JM, Gao B, Leff J, Flores SC. Neutrophil-generated free radicals: possible mechanisms of injury in adult respiratory distress syndrome. Environ Health Perspect 1994; 102 (Suppl 10): 57-60.
13. Murphy PG, Bennett JR, Myers DS, Davies MJ, Jones JG. The effect of propofol anaesthesia on free radical-induced lipid peroxidation in rat liver microsomes. Eur J Anaesthesiol 1993; 10: 261-6.
14. Mathy-Hartert M, Deby-Dupont G, Hans P, Deby C, Lamy M. Protective activity of propofol, Diprivan and intralipid against active oxygen species. Mediators Inflamm 1998; 7: 327-33.
15. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68: 613-8.
16. Heine J, Leuwer M, Scheinichen D, Arseniev L, Jaeger K, Piepenbrock S. Flow cytometry evaluation of the in vitro influence of four i.v. anaesthetics on respiratory burst of neutrophils. Br J Anaesth 1996; 77: 387-92.
17. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, Niwa Y. Propofol inhibits human neutrophil functions. Anesth Analg 1998; 87: 695-700.
18. Aoki H, Mizobe T, Nozuchi S, Hiramatsu N. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation. Anesthesiology 1998; 88: 362-70.
19. Galley HF, Dubbels AM, Webster NR. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 1998; 86: 1289-93.
20. Perez-Martinez A, Gonzalvez-Pinera J, Marco-Macian A, Carpintero-Moreno F, Moya-Marchante M. [Propofol in continuous perfusion as anesthetic in experimental surgery in the rabbit.] Rev Esp Anestesiol Reanim 1995; 42: 253-6.
21. Ichinohe T, Aida H, Kaneko Y. Interaction of nitrous oxide and propofol to reduce hypertensive response to stimulation. Can J Anaesth 2000; 47: 699-704.
22. Matsukawa A, Yoshimura T, Miyamoto K, Ohkawara S, Yoshinaga M. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Lab Invest 1997; 76: 629-38.
23. Demling RH. Adult respiratory distress syndrome: current concepts. New Horiz 1993; 1: 388-401.
24. Touqui L, Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today 1999; 5: 244-9.
25. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986; 133: 913-27.
26. Bernard C, Tedgui A. Cytokine network and the vessel wall. Insights into septic shock pathogenesis. Eur Cytokine Netw 1992; 3: 19-33.
27. Lamy M, Deby-Dupont G, Deby C, Pincemail J, Duchateau J, Braun M, Damas P, Roth M. Measurements of mediator cascade during adult respiratory distress syndrome. In: Artigs A, Lemaire F, Suter PM, Zapol WM, Adult Respiratory Distress Syndrome. New York: Churchill Livingstone, 1992; 71-88.
28. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237: 1171-6.
29. Spragg RG. Platelets and acute lung injury. In: Artigs A, Lemaire F, Suter PM, Zapol WM, Adult Respiratory Distress Syndrome. New York: Churchill Livingstone, 1992; 89-94.
30. Christman BW, Lefferts PL, Blair IA, Snapper JR. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep. Am Rev Respir Dis 1990; 142: 1272-8.
31. Glauser FL, Fairman RP. The uncertain role of the neutrophil in increased permeability pulmonary edema. Chest 1985; 88: 601-7.
32. Basu S, Mutschler DK, Larsson AO, Kiiski R, Nordgren A, Eriksson MB. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001; 50: 341-8.
33. Inada T, Taniuchi S, Shingu K, Kobayashi Y, Fujisawa J, Nakao S. Propofol depressed neutrophil hydrogen peroxide production more than midazolam, whereas adhesion molecule expression was minimally affected by both anesthetics in rats with abdominal sepsis. Anesth Analg 2001; 92: 437-41.
34. Crozier TA, Muller JE, Quittkat D, Sydow M, Wuttke W, Kettler D. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994; 72: 280-5.
35. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000; 28: 1101-6.
36. Hirakata H, Nakamura K, Yokubol B, Toda H, Hatano Y, Urabe N, Mori K. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. Anesthesiology 1999; 91: 1361-9.
37. De La Cruz JP, Zanca A, Carmona JA, de la Cuesta FS. The effect of propofol on oxidative stress in platelets from surgical patients. Anesth Analg 1999; 89: 1050-5.